ZA801555B - Chromium acetylacetonate as a dietary supplement and pharmaceutical agent - Google Patents

Chromium acetylacetonate as a dietary supplement and pharmaceutical agent

Info

Publication number: ZA801555B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical agent; chromium; dietary supplement; chromium acetylacetonate; iii
Prior art date: 1979-03-19

Application number

ZA00801555A

Other languages

English (en)

Inventor

M Anderson

D Riley

J Rotruck

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-19

Filing date

1980-03-18

Publication date

1981-04-29

1980-03-18 Application filed by Procter & Gamble filed Critical Procter & Gamble

1981-04-29 Publication of ZA801555B publication Critical patent/ZA801555B/xx

Links

239000008177 pharmaceutical agent Substances 0.000 title abstract 2
XEHUIDSUOAGHBW-UHFFFAOYSA-N chromium;pentane-2,4-dione Chemical compound [Cr].CC(=O)CC(C)=O.CC(=O)CC(C)=O.CC(=O)CC(C)=O XEHUIDSUOAGHBW-UHFFFAOYSA-N 0.000 title 1
235000015872 dietary supplement Nutrition 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
229910052804 chromium Inorganic materials 0.000 abstract 1
239000011651 chromium Substances 0.000 abstract 1
BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 abstract 1
-1 chromium(III) compound Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
230000002218 hypoglycaemic effect Effects 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
239000013589 supplement Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/92—Ketonic chelates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Polymers & Plastics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Food Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Zoology (AREA)
Hematology (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Husbandry (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Seeds, Soups, And Other Foods (AREA)

ZA00801555A 1979-03-19 1980-03-18 Chromium acetylacetonate as a dietary supplement and pharmaceutical agent ZA801555B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2138279A	1979-03-19	1979-03-19

Publications (1)

Publication Number	Publication Date
ZA801555B true ZA801555B (en)	1981-04-29

Family

ID=21803870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA00801555A ZA801555B (en)	1979-03-19	1980-03-18	Chromium acetylacetonate as a dietary supplement and pharmaceutical agent

Country Status (10)

Country	Link
US (1)	US4571391A (de)
EP (1)	EP0016496B1 (de)
JP (1)	JPS565414A (de)
AT (1)	ATE5049T1 (de)
AU (1)	AU536196B2 (de)
CA (1)	CA1154672A (de)
DE (1)	DE3065342D1 (de)
IE (1)	IE49650B1 (de)
NZ (1)	NZ193164A (de)
ZA (1)	ZA801555B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6831881A (en) *	1980-03-31	1981-10-08	Procter & Gamble Company, The	Chromium complexes as dietary supplements and pharmaceutical agents
JPS5991861A (ja) *	1982-11-17	1984-05-26	Bikou:Kk	栄養補助食品カルシウム粒
DE3334516A1 (de) *	1983-09-23	1985-04-11	Siemens AG, 1000 Berlin und 8000 München	Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen
DE3783206T2 (de) *	1986-10-27	1993-05-27	Abbott Lab	Fluessige naehrwert-tabelle fuer glukose-intoleranz.
IL95220A0 (en) *	1989-07-28	1991-06-10	Thymax Corp	Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
US5420108A (en) *	1992-09-14	1995-05-30	Shohet; Isaac H.	Method of controlling diabetes mellitus
US5811463A (en) *	1993-10-06	1998-09-22	University Of British Columbia	Compositions and method for relaxing smooth muscles
US5631284A (en) *	1993-10-06	1997-05-20	University Of British Columbia	Compositions and methods for relaxing smooth muscles
JP2005525401A (ja) *	2002-04-23	2005-08-25	ニュートリション２１、インコーポレイテッド	薬剤誘発インスリン抵抗性を阻害するためのクロム組成物およびその使用方法
US7247328B2 (en) *	2002-05-31	2007-07-24	Zinpro Corporation	Chromium (III) alpha amino acid complexes
US20060029642A1 (en)	2004-08-03	2006-02-09	Dusan Miljkovic	Methods and compositions for improved chromium complexes
US20060083824A1 (en) *	2004-10-20	2006-04-20	Pbm Products Llc	Nutritional supplements for glucose intolerant individuals
MX2009008135A (es) *	2007-01-31	2009-08-12	Nutrition 21 Inc	Uso de histidinato de cromo para tratamiento de alteraciones cardiometabolicas.
EP3050568B1 (de)	2007-03-13	2020-12-02	JDS Therapeutics, LLC	Verfahren und zusammensetzungen zur verzögerten freisetzung von chrom
WO2009002867A2 (en)	2007-06-26	2008-12-31	Nutrition 21, Inc.	Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US9585898B2 (en)	2008-02-11	2017-03-07	Kenneth O. Russell	Method for the reduction of dangerous blood sugar levels
US8932372B2 (en)	2010-02-02	2015-01-13	Celanese International Corporation	Integrated process for producing alcohols from a mixed acid feed
EP4070801A1 (de) *	2011-03-01	2022-10-12	Nutrition 21, LLC	Zusammensetzungen aus insulin und chrom zur behandlung und vorbeugung von diabetes, hypoglykämie und verwandten erkrankungen
CA3014308A1 (en)	2016-02-11	2017-08-17	Nutrition 21, Llc	Chromium containing compositions for improving health and fitness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3134797A (en) *	1960-06-13	1964-05-26	Diamond Alkali Co	Preparation of chromium complexes of beta-diketones
US3914410A (en) *	1972-06-13	1975-10-21	Bristol Myers Co	Method for preparing sucrose composition containing chromium III salt
US3925433A (en) *	1973-09-10	1975-12-09	Zinpro Corp	1:1 And 2:1 chromium, alpha amino acid complex salts

1980
- 1980-03-07 AT AT80200219T patent/ATE5049T1/de not_active IP Right Cessation
- 1980-03-07 DE DE8080200219T patent/DE3065342D1/de not_active Expired
- 1980-03-07 EP EP80200219A patent/EP0016496B1/de not_active Expired
- 1980-03-17 CA CA000347821A patent/CA1154672A/en not_active Expired
- 1980-03-17 AU AU56502/80A patent/AU536196B2/en not_active Ceased
- 1980-03-18 NZ NZ193164A patent/NZ193164A/en unknown
- 1980-03-18 ZA ZA00801555A patent/ZA801555B/xx unknown
- 1980-03-18 IE IE547/80A patent/IE49650B1/en unknown
- 1980-03-19 JP JP3569380A patent/JPS565414A/ja active Pending
- 1980-11-07 US US06/205,042 patent/US4571391A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE5049T1 (de)	1983-11-15
US4571391A (en)	1986-02-18
IE49650B1 (en)	1985-11-13
NZ193164A (en)	1984-12-14
EP0016496A1 (de)	1980-10-01
AU5650280A (en)	1980-09-25
DE3065342D1 (en)	1983-11-24
CA1154672A (en)	1983-10-04
IE800547L (en)	1980-09-19
AU536196B2 (en)	1984-04-19
JPS565414A (en)	1981-01-20
EP0016496B1 (de)	1983-10-19

Publication	Publication Date	Title
DE3065342D1 (en)	1983-11-24	Chromium acetylacetonate as a dietary supplement and pharmaceutical agent
PH23014A (en)	1989-03-03	Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
SG115193G (en)	1994-01-21	Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus
FI875533A0 (fi)	1987-12-16	Insulinpreparat foer non-parenteral dosering.
PH31617A (en)	1999-01-12	Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
ATE163849T1 (de)	1998-03-15	Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
CA2029865A1 (en)	1990-10-22	Continuous/bolus infusor
DE59309714D1 (de)	1999-09-09	Pharmazeutische und/oder kosmetische Zubereitung
HU910979D0 (en)	1991-10-28	Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
CA2113856A1 (en)	1994-10-15	Antidiabetic Agent
EP0019403A3 (en)	1981-10-07	Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
EP0424156A3 (en)	1992-04-22	Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
GB2002516A (en)	1979-02-21	Device for preparation of liquid control solutions
EP0037144A3 (de)	1981-11-25	Chromkomplexe als Diätzulage und pharmazeutische Mittel
ES2166406T3 (es)	2002-04-16	Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
HK17880A (en)	1980-04-11	N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
PL267525A1 (en)	1988-03-03	Agent for agricultural use
FI843695A7 (fi)	1985-03-24	Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
FR2475898B1 (de)	1983-05-06
ES279057U (es)	1985-02-01	Jeringuilla para inyecciones
FR2390165A1 (fr)	1978-12-08	Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant
Kitamoto	1976	Social Needs and Medical Society
MX9703359A (es)	1997-08-30	Acidos 2,2-dicloroalcancarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar resistencia a la insulina.
UA7361A1 (uk)	1995-09-29	Препарат для лікування і профілактики авітамінозів сільськогосподарських тварин "інсолвіт"